Methimazole - CAS 60-56-0
Catalog number:
60-56-0
Category:
Inhibitor
Not Intended for Therapeutic Use. For research use only.
Molecular Formula:
C4H6N2S
Molecular Weight:
114.17
COA:
Inquire
Targets:
Others
Description:
Methimazole (also known as Tapazole or Thiamazole or MMI) is an antithyroid drug,and part of the thioamide group. Like its counterpart propylthiouracil, a major side effect of treatment is agranulocytosis.
Publictions citing BOC Sciences Products
  • >> More
Purity:
>98%
MSDS:
Inquire
1.SERIAL CHANGES OF LIVER FUNCTION TESTS BEFORE AND DURING METHIMAZOLE TREATMENT IN THYROTOXIC PATIENTS.
Niculescu DA1, Dusceac R2, Galoiu SA1, Capatina CA1, Poiana C1. Endocr Pract. 2016 Apr 4. [Epub ahead of print]
Objective Overt hyperthyroidism and methimazole (MMI) treatment are frequently associated with abnormal liver function tests (LFT). We describe the serial changes of LFT in MMI-treated hyperthyroid patients. Methods We retrospectively analyzed all 77 patients presenting with newly diagnosed overt hyperthyroidism (59 Graves diseases, 11 toxic nodular goiters, 4 toxic adenomas, 3 amiodarone-induced thyrotoxicosis) between 2012-2014. All patients started MMI 10 to 60 mg/day that was gradually tapered. We measeured TSH, freeT4, alanine aminotransferase (ALT) and aspartate aminotrasnferase (AST) at baseline and at 6 weeks, 4.5 months and 10 months after starting the MMI treatment. The concomitant medication was stable during MMI treatment. Results At baseline, 25 patients (32.5%) had abnormal LFT, of which 5 had ALT or AST levels over 2 × upper limit of normal (ULN). In most patients with baseline abnormal LFT, MMI treatment resulted in a normalization of serum ALT and AST.
2.Hampered Lung Maturation in Methimazole-Induced Hypothyroidism in Fetal Chicken: Morphological and Molecular Correlates to Human Fetal Development.
Bjørnstad S1, Samara A, Erichsen A, Paulsen RE, Glover JC, Roald B. Neonatology. 2016;110(2):83-92. doi: 10.1159/000444656. Epub 2016 Apr 13.
BACKGROUND: Molecular understanding of lung development is crucial for developing therapies and diagnostic tools. Animal models with altered thyroid hormone signaling provide mechanistic insight into thyroid-dependent neonatal lung disease. Repression of Klf2 (Krüppel-like factor 2), a suggested T3 target gene, is associated with disrupted lung development in mice. Klf2 is proposed to be specifically involved in type I pneumocyte differentiation.
3.Graves' disease in a mediastinal mass presenting after total thyroidectomy for nontoxic multinodular goiter: a case report.
Cunha FM1,2, Rodrigues E3,4, Oliveira J3,4, Saavedra A3,4, Vinhas LS5, Carvalho D3,4. J Med Case Rep. 2016 Mar 31;10(1):70. doi: 10.1186/s13256-016-0878-7.
BACKGROUND: Thyrotoxicosis after total thyroidectomy is mostly iatrogenic. Rarely, a hyperfunctional thyroid remnant or ectopic tissue may be the cause. There are few cases of Graves' disease arising from thyroid tissue located in the mediastinum and none in which Graves' disease was diagnosed only after surgery. We report the case of a patient with Graves's disease in a mediastinal thyroid mass presenting 7 years after total thyroidectomy for nontoxic goiter.
4.Predicting relapse of Graves' disease following treatment with antithyroid drugs.
Liu L1, Lu H1, Liu Y2, Liu C1, Xun C3. Exp Ther Med. 2016 Apr;11(4):1453-1458. Epub 2016 Feb 9.
The aim of the present study was to monitor long term antithyroid drug treatments and to identify prognostic factors for Graves' disease (GD). A total of 306 patients with GD who were referred to the Endocrinology Clinic at Weifang People's Hospital (Weifang, China) between August 2005 and June 2009 and treated with methimazole were included in the present study. Following treatment, patients were divided into non-remission, including recurrence and constant treatment subgroups, and remission groups. Various prognosis factors were analyzed and compared, including: Patient age, gender, size of thyroid prior to and following treatment, thyroid hormone levels, disease relapse, hypothyroidism and drug side-effects, and states of thyrotropin suppression were observed at 3, 6 and 12 months post-treatment. Sixty-five patients (21.2%) were male, and 241 patients (78.8%) were female. The mean age was 42±11 years, and the follow-up was 31.5±6.8 months.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related Products


CAS 13450-70-9 CI 600

CI 600
(CAS: 13450-70-9)

CI 600 is a bio-active chemical, but no detailed information has been published yet.

CAS 61301-33-5 Schisandrin C

Schisandrin C
(CAS: 61301-33-5)

Schisandrin C is a phytochemical lignan isolated from Schizandra chinensis Baill, which shows anticancer-effects in human leukemia U937 cells.

BMS779333
(CAS: 1095181-60-4)

BMS779333 is a novel AR pan-antagonist with significantly improved cardiovascular and metabolic profiles. It has anti- tumor effect.

CAS 16051-77-7 Isosorbide mononitrate

Isosorbide mononitrate
(CAS: 16051-77-7)

A coronary vasodilator that does not require hepatic biotransformation

CAS 136-77-6 4-Hexylresorcinol

4-Hexylresorcinol
(CAS: 136-77-6)

4-Hexylresorcinol, a phenol derivative, could be commonly used as antioxidant, vermifuge and food additives.

MitoE10
(CAS: 1810703-63-9)

MitoE10, a mitochondria-targeted antioxidants comprising a lipophilic triphenylphosphonium cation attached to the antioxidant chroman moiety of vitamin E by an ...

CAS 721-50-6 Prilocaine

Prilocaine
(CAS: 721-50-6)

Prilocaine is a local anesthetic of the amino amide type.

CAS 37893-02-0 Flubenzimine

Flubenzimine
(CAS: 37893-02-0)

Flubenzimine is a synthetic anthelmintic chemical.

AG 1812
(CAS: 114559-57-8)

This active molecular is a bio-active chemical and detailed information has not been published yet.

CAS 35607-20-6 Avridine

Avridine
(CAS: 35607-20-6)

Avridine is a potent synthetic non-immunogenic adjuvant that used to induce arthritis in Lewis (LEW) and DA rats.

CAS 49697-38-3 Rimexolone

Rimexolone
(CAS: 49697-38-3)

Rimexolone is a glucocorticoid steroid used to treat inflammation in the eye for the treatment of postoperative inflammation following ocular surgery and in the...

CAS 174721-08-5 Ginsenoside Rh4

Ginsenoside Rh4
(CAS: 174721-08-5)

Ginsenoside Rh4 is a saponin isolated from the roots of Panax notoginseng (Burk.) F. H. Chen; used as adjuvant with low or non-haemolytic effect.

CAS 5578-73-4 Sanguinarine chloride hydrate

Sanguinarine chloride hydrate
(CAS: 5578-73-4)

Sanguinarine is a benzylisoquinoline alkaloid isolated from Papaveraceae with antimicrobial, anti-inflammatory, and anti-oxidant properties.

CAS 52286-74-5 Ginsenoside Rg2

Ginsenoside Rg2
(CAS: 52286-74-5)

Ginsenoside Rf, extracted from the traditional Chinese herb ginseng used as an aldose reductase inhibitor and my exert anti-inflammatory and immunomodulatory ac...

CAS 54706-99-9 20-Deoxyingenol

20-Deoxyingenol
(CAS: 54706-99-9)

20-Deoxyingenol is a diterpene derivative of Ingenol, isolated from the seeds of Euphorbia lathyris L., which has anti-tumor activity when used topically for th...

Hexa-His

Hexa-His, consisting of 6 His residues in a row, called His-Tag, is used as a metal binding site for the recombinant protein. His-Tag sequence can be placed on ...

CAS 616-91-1 Acetylcysteine

Acetylcysteine
(CAS: 616-91-1)

Acetylcysteine is used mainly as a mucolytic, protects against acetaminophen overdose-induced hepatotoxicity by maintaining or restoring hepatic concentrations ...

CAS 100929-71-3 β-NADPH tetra (cyclohexylammonium) salt

β-NADPH tetra (cyclohexylammonium) salt
(CAS: 100929-71-3)

β-NADPH tetra(cyclohexylammonium), generating in vivio by the pentose phosphate pathway, is a a ubiquitous cofactor and biological reducing agent.

CAS 529-59-9 Genistin

Genistin
(CAS: 529-59-9)

Genistinis, a derivative of Genistein, is selective inhibitor of mammalian terminal deoxynucleotidyl transferase.

CAS 59-67-6 Nicotinic Acid

Nicotinic Acid
(CAS: 59-67-6)

Nicotinic Acid is a water-soluble vitamin belonging to the vitamin B family.

Chemical Structure

CAS 60-56-0 Methimazole

Quick Inquiry

Verification code

Featured Items